BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29475470)

  • 21. Progress in Circulating Tumor Cell Research Using Microfluidic Devices.
    Gwak H; Kim J; Kashefi-Kheyrabadi L; Kwak B; Hyun KA; Jung HI
    Micromachines (Basel); 2018 Jul; 9(7):. PubMed ID: 30424286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.
    Bellassai N; Spoto G
    Anal Bioanal Chem; 2016 Oct; 408(26):7255-64. PubMed ID: 27497966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid biopsy technologies for hematological diseases.
    Fu Y; Zhang Y; Khoo BL
    Med Res Rev; 2021 Jan; 41(1):246-274. PubMed ID: 32929726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System.
    Lemaire CA; Liu SZ; Wilkerson CL; Ramani VC; Barzanian NA; Huang KW; Che J; Chiu MW; Vuppalapaty M; Dimmick AM; Carlo DD; Kochersperger ML; Crouse SC; Jeffrey SS; Englert RF; Hengstler S; Renier C; Sollier-Christen E
    SLAS Technol; 2018 Feb; 23(1):16-29. PubMed ID: 29355087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic technologies for circulating tumour cells and exosomes.
    Shao H; Chung J; Issadore D
    Biosci Rep; 2015 Nov; 36(1):e00292. PubMed ID: 26604322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
    Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
    Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative Enrichment of Circulating Tumor Cells in Blood Using a Microfluidic Chip.
    Cognart HA; Chang CP
    Methods Mol Biol; 2017; 1547():167-174. PubMed ID: 28044295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Droplet microfluidics for CTC-based liquid biopsy: a review.
    Jiang L; Yang H; Cheng W; Ni Z; Xiang N
    Analyst; 2023 Jan; 148(2):203-221. PubMed ID: 36508171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.
    He M; Zeng Y
    J Lab Autom; 2016 Aug; 21(4):599-608. PubMed ID: 27215792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic-Based Exosome Analysis for Liquid Biopsy.
    Lin B; Lei Y; Wang J; Zhu L; Wu Y; Zhang H; Wu L; Zhang P; Yang C
    Small Methods; 2021 Mar; 5(3):e2001131. PubMed ID: 34927834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cell isolation and diagnostics: toward routine clinical use.
    van de Stolpe A; Pantel K; Sleijfer S; Terstappen LW; den Toonder JM
    Cancer Res; 2011 Sep; 71(18):5955-60. PubMed ID: 21896640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging techniques in molecular detection of circulating tumor cells.
    Cho WC
    Expert Rev Mol Diagn; 2014 Mar; 14(2):131-4. PubMed ID: 24437950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
    Li G; Tang W; Yang F
    Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
    Theil G; Fornara P
    Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of liquid biopsies for the detection and management of prostate cancer.
    Lu YT; Delijani K; Mecum A; Goldkorn A
    Cancer Manag Res; 2019; 11():5271-5291. PubMed ID: 31239778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.